Current serological methods of testing and automation

Transfusion Microbiology

Volumn , Issue , 2008, Pages 159-172

  Rogan, Peter D ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70449368031     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545245.015     Document Type: Chapter

References (18)

1. Alter, M. J., Kuhnert, W. L. and Finelli, L. (2003) Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep, 52 (RR-3), 1-13.
2. Barbara, J. A. J. (1983) Microbiology in blood transfusion, p. 72. Bristol, John Wright &Sons Ltd.
3. Barbara, J., Ramskill, S., Perry, K., et al. (2006) The National Blood Service (England) approach to evaluation of kits for detecting infectious agents. Transfus Med Rev, 21 (2), 147-58.
4. Bayer Healthcare, LCC Diagnostic Division, 511 Benedict Avenue, Tarrytown, NY 10591, USA (available at: Www.labnews.com).
5. Blumberg, B. S., Alter, H. J. and Visnich, S. (1965) A ‘new’ antigen in leukaemia sera. J Am Med Assoc, 191, 541.
6. Carman, W. F. and Thomas, H. C. (1991) Genetically defined variants of hepa-titis B virus. Rev Med Virol, 1, 29-39.
7. Carman, W., Thomas, H. and Domingo, E. (1993) Viral genetic variation: Hepa-titis B virus as a clinical example. Lancet, 341, 349-53.
8. Engvall, E. and Perlmann, P. (1971) Enzyme-linked Immunosorbent Assay (ELISA)-quantitative assay of immunoglobulin G. Immunochemistry, 8 870-4.
9. Gurtler, L. G., Zekeng, L., Simon, F., et al. (1995) Reactivity of five anti-HIV1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots. J Virol Methods, 51, 177-84.
10. Hashida, S., Hashinaka, K., Nishikata, I., et al. (1996) Earlier diagnosis of HIV-1 infection by simultaneous detection of p24 antigen and antibody IgGs to p17 and reverse transcriptase in serum with enzyme immunoassay. J Clin Lab Anal, 10, 213-9.
11. Jongerius, J. M., Wester M., Cuypers, H. T., et al. (1998) New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion, 38, 56-9.
12. Kitchen, A. D. and Barbara, J. A. J. (1997) The development of tests for antibody to hepatitis C virus. In The Molecular Medicine of Viral Hepatitis, eds T. J. Harrison and A. J. Zuckerman. Chichester, John Wiley and Sons Ltd.
13. Loussert-Ajaka, I., Ly, T. D., Chaix, M.L., et al. (1994) HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet, 343, 1393-4.
14. Muller, F. in International Forum (1981) Does it make sense for blood transfu-sion services to continue the time-honoured syphilis screening with cardio-lipin antigen? Vox Sang, 41, 188.
15. Stramer, S. L., Glynn, S. A., Kleinman, S. H., et al. (2004) Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Eng J Med, 351, 760-8.
16. Vamvakas, E. C. (2005) Is white blood cell reduction equivalent to anti-body screening in preventing transmission of cytomegalovirus by transfu-sion? A review of the literature and meta-analysis. Trans Med Rev, 19 (3), 181-99.
17. Van Weemen, B. K. and Schuurs, A. H. W. M. (1971) Immunoassay using antigen-enzyme conjugates. FEBS Letters, 15, 232-6.
18. Zaaijer, H. L., Vrielink, H. and Koot, M. (2001) Early detection of hepatitis B surface antigen and detection of HBsAg mutants: A comparison of five assays. Vox Sang, 81, 219-21.